Driving Innovation in Vaccines Procurement Intelligence
The vaccines category is anticipated to grow at a CAGR of 4.7% from 2023 to 2030. They can be classified mainly into six types - Live-attenuated, inactivated, sub-unit, toxoid, viral vector, and messenger RNA (mRNA) vaccines. Among these, the mRNA sector held the largest share of 39% in 2022. The growth of the category is mainly attributed to the rising requirement for effective immunization, increasing R&D investments coupled with technological advancements, and a wider accessibility of the product especially in lower-income countries. In recent times, the emergence of new COVID variants and other infectious diseases such as “Disease X”, Nipah virus, Ebola, Crimean-Congo Hemorrhagic Fever, Rift Valley Fever (RVF), etc. are further boosting the product demand. The Developing Country Vaccine Manufacturers (DCVMs) play a crucial role in supplying more than 50% of the vaccines utilized in immunization programs of developing nations. The DCVM is a voluntary alliance comprised of 40 va...